Posted on December 10, 202512/10/25
Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis
Posted on December 3, 202512/3/25
New Direct-to-Employer Access Model Provides Options for Employers to Improve Access to Weight Loss Medications
Posted on October 16, 202510/16/25
Let’s Be DIRECT: We Have An Access and Affordability Problem to Solve
Posted on October 9, 202510/9/25
Navigating the New HTA Landscape: Pamela Vo on Strategic Evidence Planning
Posted on October 1, 202510/1/25
Brave New Commercialization World: Reimagining Global Launch Strategies in Life Sciences
Posted on September 30, 20259/30/25
Strategic PICO Planning: Navigating Oncology Markets with NAVLIN by EVERSANA
Posted on September 30, 20259/30/25
Strategic PICO Planning: Enhancing Early-Phase Development for Market Access
Posted on August 25, 20258/25/25
Evaluation of HTA Frameworks for In Vivo Diagnostics: Assessing Methodological Gaps and Implications for Market Access
Posted on August 22, 20258/22/25
Navigating MFN: Alan Crowther on What Pharma Brands Must Know Now
Posted on July 22, 20257/22/25